openPR Logo
Press release

Injectable Nanomedicines Market Poised to Witness Strong Revenue Growth, as Liposome-based Nanomedicines Continue to Advance

02-20-2019 02:11 PM CET | Health & Medicine

Press release from: Persistence Market Research (PMR)

Injectable Nanomedicines Market Poised to Witness Strong

The growth of the injectable nanomedicines market is attributed to the growing use of liposomal drugs and increase in treatment seeking population across the globe. According to a latest research by the company, the global liposomes market is expected to account for revenues over US$ 300 Mn in terms of value by 2026 end. Injectable nanomedicines market is expected to witness significant growth with CAGR pegged at 8.1% through 2026. Manufacturers of injectable nanomedicines are targeting chronic diseases and cancers.

To know key findings Request Sample Report @: https://www.persistencemarketresearch.com/samples/25999

Revenues from North America injectable nanomedicines market is expected to expand at significant CAGR and it is estimated to remain as dominant regional market for injectable nanomedicines due to large presence of hospitals and advanced healthcare facilities. Europe is also expected to be one of the leading regional markets for injectable nanomedicines as most of the major academic research institutes and R&D institutes for specialized drugs are located in the region. An ageing population and increasing prevalence of chronic illnesses is estimated to lead to rising demand for injectable nanomedicines.

Injectable nanomedicines are considered as an emerging field with many companies spending on R&D to explore this field in greater depth. There are both small and established market players investing in injectable nanomedicines. Majority of injectable nanomedicines were produced by small pharmaceutical companies which were later acquired by established market players. Small pharmaceutical companies are exploring nanotechnology to develop advanced drugs and technologies. For instance, Pfizer collaborated with BIND Therapeutics Inc for the development of nanoparticles, called Accurins.

Request for Report Methodology @: https://www.persistencemarketresearch.com/methodology/25999

The growing adoption of injectable nanomedicines for cancer treatment is expected to boost revenues generated from injectable nanomedicines thereby boost the growth of the global injectable nanomedicines market. Cancer is one of the leading causes of deaths globally, with approximately 1,688,780 new cases and 600,920 deaths in 2017. Researchers note that efficacy of traditional cancer therapeutics is often modest to negligible owing to the low specificity and stability. For obtaining optimal therapeutic effects, the right drug should be delivered at the targeted microenvironment at the right time with the right concentration.

Injectable nanomedicines are advantageous over all the conventional medicines for cancer therapy. Injectable nanomedicines contain drugs loaded in nanoparticles, which help to overcome the biological barriers, improve the efficacy and reduce morbidity. These medicines further improve the bioavailability and toxicity profile of cancer treatments. All these factors are projected to drive the growth of the global injectable nanomedicines market during the forecast period.

The global injectable nanomedicines market is segmented based on drug type, applications, and end user.

Based on drug type, the injectable nanomedicines market has been segmented into liposomes, micelles, nanocrystals, polymeric nanoparticles, metallic nanoparticles, mesoporous silica nanoparticles and others. The liposomal drug type is projected to be the leading segment holding maximum share in the global injectable nanomedicines market. Liposomes mimic biological cells and are highly biocompatible, which makes them an ideal candidate for a drug delivery system among global injectable nanomedicines manufacturers.

Based on application, the injectable nanomedicines market has been segmented into cancer, central nervous system disease, cardiovascular disease, infection control, inflammatory disease and others. In terms of revenue, cancer application dominated the global injectable nanomedicines market in 2017 and is projected to continue to do so throughout the forecast period. After cancer, CNS application is expected to account for significant share in the market.

The global injectable nanomedicines market is competitive, with large number of players. However, availability of adequate sterile drug manufacturing facilities is estimated to pose serious problem in injectable nanomedicines market throughout the forecast period, especially in emerging markets.

Get full Report Now: https://www.persistencemarketresearch.com/checkout/25999

Examples of some of the key companies operating in the market are Pfizer Inc., Merck & Co, Inc., Lupin, Janssen Biotech Inc., Hoffmann-La Roche Ltd., Amgen Inc., Teva Pharmaceutical Industries Ltd., Pacira Pharmaceuticals Inc., Celgene Corporation and Bausch & Lomb Incorporated, among others.

About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Injectable Nanomedicines Market Poised to Witness Strong Revenue Growth, as Liposome-based Nanomedicines Continue to Advance here

News-ID: 1603894 • Views: 254

More Releases from Persistence Market Research (PMR)

Virtual Desktop Infrastructure Market Unit Sales to Witness heightened Growth in …
As per findings of a new market research report by Persistence Market Research, the global virtual desktop infrastructure market reached a valuation of nearly US$ 3.5 Bn in 2019, and is anticipated to exhibit a CAGR of around 12% during the forecast period of 2020 to 2030.The adoption of BYOD allows employees to bring their own devices in the organization, which allows then to access company information and applications via virtual desktop infrastructure. With such a BYOD policy, both, employers
Physician Scheduling Systems Market to Generate Profitable Avenues for Existing …
As per findings of a new market research report by Persistence Market Research, the global physician scheduling system market reached US$ 311 Mn in 2019 and is anticipated to exhibit a healthy CAGR of 14% during the forecast period of 2020 to 2030. Adoption of physician scheduling systems is increasing across the world, as physicians encounter difficulties with increasing administrative tasks and regulations, which affects their ability to offer patient care, and they struggle to sustain their practices. To combat administrative work
Demand for Rfid Electronic Toll Collection System Market from Major End-use Sect …
Many toll collection systems have already been developed with RFID technology, which is used to verify the identity of vehicles. RFID technology can provide new capabilities as well as an efficient method to manage, analyze, and collect information of vehicles at toll plazas. RFID electronic toll collection lanes reduce the traffic at toll booths. Increasing number of RFID lane systems, resulting in increased demand for integration, support services, and maintenance,
Smart Home Cloud Platform Market Unit Sales to Witness heightened Growth in the …
In a smart home, appliances such as ACs, TVs, geysers, and lights have the potential to communicate with a cloud server. The cloud server communicates with these smart devices by sending and receiving signals through smartphones, laptops, or voice-enabled digital assistant devices.A homeowner can make his/her existing home smart by integrating cloud-based technology with it. Cloud computing enables homeowners to remotely access their home appliances, even if they are miles

All 5 Releases


More Releases for Injectable

Global Specialty Injectable Generics Market Research Report
This report studies the global Specialty Injectable Generics market status and forecast, categorizes the global Specialty Injectable Generics market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Pfizer Fresenius Mylan N.V. Teva Pharmaceutical Hikma Pharmaceuticals Novartis AG Uman Pharma Baxter Par Pharmaceutical
Global Injectable Drug Delivery Market to 2028 |Retail Pharmacies, Injectable Dr …
Market Research Hub (MRH) has carefully analyzed this research study titled Injectable Drug Delivery Market: Self-injectors to Remain Fastest Growing Product Type During the Forecast Period: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028, which is available on its online portal. The aim of this assessment is to highlight the various projections expected to occur in the global market for Injectable Drug Delivery. Readers can gain knowledge related to prime
Global and Chinese Sterile Injectable Drugs Market
https://www.qandqmarketresearch.com/reports/sterile-injectable-drugs2018-market-4 The Global and Chinese Sterile Injectable Drugs Industry, 2013-2023 Market Research Report is a professional and indepth study on the current state of the global Sterile Injectable Drugs industry with a focus on the Chinese market. The report provides key statistics on the market status of the Sterile Injectable Drugs manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report
Injectable Targeted Therapy Market: Primary application of injectable targeted t …
Targeted delivery is a clinical treatment used to deliver medication in patients to increase the concentration of medication in some parts of the body. Target specific drug delivery is localized, prolonged, targeted and have protected drug interaction with the diseased tissue. The advantage of injectable targeted therapy was the decrease in frequency of the dosages that are delivered to the patient, it more uniform effect of the drug, reduction of
Global Facial Injectable Market – Forecast, 2013-2021
Facial Injectable Market Wiseguyreports.Com Adds “Facial Injectable Market -Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2022” To Its Research Database. Description: Facial Injectable products, also known as dermal fillers are products that help in trending applications such as bioengineering or facial rejuvenation. With age, facial skin is bound to lose subcutaneous fat naturally and
2017 - 2022: Injectable Targeted Therapy Global Market
Researchmoz added Most up-to-date research on "2017 - 2022: Injectable Targeted Therapy Global Market" to its huge collection of research reports. Targeted delivery is a clinical treatment used to deliver medication in patients to increase the concentration of medication in some parts of the body. Target specific drug delivery is localized, prolonged, targeted and have protected drug interaction with the diseased tissue. The advantage of injectable targeted therapy was the decrease